X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology

This publication has 72 references indexed in Scilit:

• Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-α
  Clinical Immunology and Immunopathology, 1990
• Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease
  American Journal of Medical Genetics, 1989
• Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection
  Journal of Clinical Immunology, 1989
• Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma Globulin
  New England Journal of Medicine, 1988
• Thymic lesions in fatal infectious mononucleosis
  Clinical Immunology and Immunopathology, 1987
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
  Nature, 1985
• X-Linked Lymphoproliferative Syndrome Registry report
  The Journal of Pediatrics, 1980
• Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome
  Clinical Immunology and Immunopathology, 1978
• Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative Syndrome
  New England Journal of Medicine, 1977
• PATHOGENESIS AND PHENOTYPES OF AN X-LINKED RECESSIVE LYMPHOPROLIPERATIVE SYNDROME
  The Lancet, 1976